GOLD

From complicated separations for drug development and crop-to-table processing solutions to enabling protein-rich diets and innovative healthcare solutions, DuPont´s broad range of Life Science products improve the quality of life for humans, plants, and animals in our world. As a global market leader in adsorbents, chromatography resins, and ion exchange resins, DuPont Water Solutions offers a broad range of products designed for use in bioprocessing and drug synthesis. Whether it’s new advanced gene therapies or a conventional small molecule drug, DuPont has a wide range of polymeric purification resins to fit a multitude of applications. With a wellness optimized world at our core, our global research and development capabilities can address purification challenges in drug and diagnostics manufacturing now and in the future, resulting in better outcomes for patients and life science companies alike.

GOLD

EUROAPI is focused on reinventing active ingredient solutions to sustainably meet customers’ and patients’ needs around the world. We are a leading player in active pharmaceutical ingredients with approximately 200 products in our portfolio, offering a large span of technologies while developing innovative molecules through our Contract Development and Manufacturing Organization (CDMO) activities.
Taking action for health by enabling access to essential therapies inspires our 3,450 people every day. With strong research and development capabilities and six manufacturing sites, all located in Europe, EUROAPI ensures API manufacturing of the highest quality to supply customers in more than 80 countries. Find out more at www.euroapi.com and follow us on LinkedIn.

GOLD

Gyros Protein Technologies provides enabling peptide synthesis and bioanalytical solutions, helping scientists in research through bioprocess applications. Our peptide synthesizers PurePep® Chorus, Symphony® X, PurePep® Sonata®+, and chemistries deliver uncompromising purity, flexibility and quality in less time. Sensitive, accurate and robust nanoliter-scale immunoassays for pharmacokinetics/pharmacodynamics, immunogenicity and quantitating bioprocess impurities are performed on our proprietary platforms Gyrolab® xPand and Gyrolab xPlore™. Peptide synthesis and bioanalytical solutions: accelerate your discovery, development and manufacturing of safer biotherapeutics. Gyros Protein Technologies is part of the Biopharmaceutical Division of Mesa Laboratories, Inc.

GOLD

PolyPeptide Group AG and its consolidated subsidiaries (“PolyPeptide”) is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech, it contributes to the health of millions of patients across the world. PolyPeptide offers products and services from pre-clinical through to commercial stages, including generics. Its active custom projects pipeline reflects the opportunities from novel drug therapies in development to fight both widespread and rare diseases. Dating back to 1952, PolyPeptide today runs a global network of six cGMP-certified facilities in Europe, the U.S. and India. PolyPeptide Group AG’s shares (SIX: PPGN) are listed on SIX Swiss Exchange.

GOLD

Advances in nucleic acid therapeutics
Nucleic acid therapeutics are changing healthcare by delivering promising drugs that use new technologies and modes of action to treat disease. Several of these innovative medicines are being utilized to treat infectious diseases, protein and gene deficiencies, and many types of cancers. With more and more effort and resources being directed into this area, we may only be at the beginning stages of a revolution in medicine.

Solutions for nucleic acid therapeutic development
There are two classes of nucleic acid therapeutics: mRNA-based therapeutics or vaccines and synthetic oligonucleotide therapeutics. Learn more below about the products and technologies you’ll need as you make critical choices to successfully develop and manufacture these revolutionary

mRNA-based therapeutics and vaccines
mRNA based therapeutics and vaccines are produced biosynthetically using nucleotides, enzymes, and mRNA modification systems.

Synthetic oligonucleotide therapeutics
Synthetic oligonucleotide therapeutics are produced chemically using DNA or RNA phosphoramidites

GOLD

Tosoh Bioscience is an acknowledged global leader in liquid chromatography with a focus on bioseparations. Our chromatography experts enable our biopharma partners to provide safe and efficient therapies against life-threatening diseases.

We offer a comprehensive line of chromatography instrumentation, media and (U)HPLC columns. These are used from R&D to manufacturing to characterize and purify therapeutic peptides, proteins and oligonucleotides at lab, pilot, and commercial scale.

Tosoh Bioscience is part of the Tosoh Group, a Japanese chemical and specialty products group with over 100 companies worldwide and a workforce of about 13000 people.

SILVER

KNAUER manufactures in Berlin liquid chromatography instruments for research, routine analysis, quality assurance, and other applications. Apart from LC, KNAUER offers products for liquid handling, high-pressure dosing, flow-through detection, and more.

Customizable solutions are one of KNAUER’s strengths. Latest example is the lipid nanoparticle production equipment used for mRNA vaccines.

SILVER

CEM was founded in 1978 by our current CEO, Dr. Michael J. Collins. For over 40 years we have designed and developed laboratory instrumentation and scientific methods (both microwave-based and non-microwave technologies) that are used by major companies, prestigious research institutes, and universities around the world. We are a private company with global headquarters outside Charlotte, North Carolina, along with offices in England, Germany, Japan, France, Italy, Singapore, and Ireland.

Committed to the continuous advancement of solid-phase peptide synthesis, our goal is to develop the most effective and efficient SPPS workflow solutions for the peptide and peptidomimetic community.
Our performance- and efficiency-driven peptide synthesizer lines are available in both sequential and parallel formats, spanning research through production scale synthesis. We offer a suite of high-quality SPPS chemicals, including preloaded resins and amino acids in both bulk and conveniently pre-weighed options. Our powerful purification system streamlines peptide isolation, simplifying the transition from analytical to preparative scale.
From reagent preparation and peptide synthesis to cleavage and purification, our dedicated team of scientists and engineers strive to simplify science, start to finish.

SILVER

Quality Assistance is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products. 

With more than 40 years’ experience, Quality Assistance has become a leader in analytical sciences and holds a unique position on the market with all its laboratories on one site and 230 highly qualified professionals. 

We assist our clients from candidate selection, through non-clinical and clinical studies, to marketing authorisation, using our state-of-the-art, product-dedicated expertise in analytical sciences.